Arrowhead Research Corporation News Headlines

ARWR 
$6.39
*  
0.28
4.58%
Get ARWR Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading ARWR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ARWR Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
12/17/2014 9:20:00 AM - TheStreet


Which Biotech Will Become the Next Gilead Sciences, Inc.?
12/16/2014 9:03:02 AM - Motley Fool


Health Care Sector Update for 11/26/2014: ARWR, AMGN, AZN
11/26/2014 8:43:52 AM - MT Newswires


Earnings Reaction History: Arrowhead Research Corp., 50.0% Follow-Through Indicator, 3.8% Sensitive
11/25/2014 3:08:11 PM - MT Newswires


Arrowhead Research Q4 14 Earnings Conference Call At 4:30 PM ET
11/25/2014 3:02:00 PM - RTT News


Marina Biotech: A Forgotten And Grossly Undervalued Game Changer
11/25/2014 11:40:00 AM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer
11/25/2014 10:30:00 AM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game Changer
11/25/2014 10:30:00 AM - SeekingAlpha


After Hours Most Active for Nov 7, 2014 : F, GLW, MON, MRK, BTU, ORCL, SIRI, AAPL, MU, PPC, ARWR, ODP
11/7/2014 4:44:05 PM - NASDAQ.com News


Can Arrowhead Research Corp. Stock Recover from Its Horrendous Drop?
10/9/2014 4:09:02 PM - Motley Fool


Arrowhead explains the ARC-520 data
10/9/2014 9:18:00 AM - Seeking Alpha


Sector Update: Health Care Stocks End With Out-Sized Gains; Arrowhead Research Shot Down After Trial Data Lags Expectations
10/8/2014 3:01:30 PM - MT Newswires


Sector Update: Health Care
10/8/2014 3:00:03 PM - MT Newswires


If Gilead's Hepatitis C Treatment Grosses $10B+ Per Year, Arrowhead's Hepatitis B Treatment Is Attractive.
10/6/2014 11:57:00 AM - Seeking Alpha


Ocera Therapeutics Finally Ready To Reward Investors
10/1/2014 12:32:00 PM - Seeking Alpha


Arrowhead Research To Present In BioCentury NewsMakers Conference At 10:30 AM ET
9/26/2014 9:30:00 AM - RTT News


Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14)
9/12/2014 5:47:00 AM - Seeking Alpha


Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93, Gilead Most Likely Suitor
9/11/2014 10:49:00 AM - Seeking Alpha


Friday's ETF Movers: XBI, PIZ
8/29/2014 11:57:06 AM - BNK Invest


Tuesday's ETF Movers: XBI, XLU
8/26/2014 12:15:30 PM - BNK Invest


Cramer's Lightning Round - I'm Not Touching Potbelly (8/13/14)
8/14/2014 6:25:00 AM - Seeking Alpha


Pre-Market Most Active for Aug 13, 2014 : NCT, ENOC, SFM, MTU, KING, SEAS, M, KATE, CSIQ, XIV, ARWR, QQQ
8/13/2014 7:39:55 AM - NASDAQ.com News


Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/12/2014 2:06:00 PM - Investopedia


Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential
8/12/2014 12:27:00 PM - Seeking Alpha


Earnings Reaction History: Arrowhead Research Corp., 100.0% Follow-Through Indicator, 4.2% Sensitive
8/12/2014 9:22:19 AM - MT Newswires